Jordan vs Singapore: Prostate cancer death rate in men
Jordan
6.92 deaths per 100,000 people
in 2018
Singapore
6.86 deaths per 100,000 people
in 2022
Jordan rank
89th
Singapore rank
90th
Prostate cancer death rate in men over time
- Jordan
- Singapore
How they compare
Jordan currently reports 6.92 deaths per 100,000 people against 6.86 deaths per 100,000 people in Singapore, a difference of 0.06 deaths per 100,000 people.
The two have swapped places 2 times across 9 shared years of data; in 2008 it was Singapore ahead.
Jordan ranks 89th and Singapore ranks 90th of 111 countries.
Singapore has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Jordan | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.8 deaths per 100,000 people | 8.07 deaths per 100,000 people | 0.2682 deaths per 100,000 people | Singapore |
| 2010s | 6.39 deaths per 100,000 people | 7.06 deaths per 100,000 people | 0.6719 deaths per 100,000 people | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prostate cancer death rate in men, Jordan or Singapore?
- Jordan, at 6.92 deaths per 100,000 people against 6.86 deaths per 100,000 people in Singapore as of 2018.
- What is the difference in prostate cancer death rate in men between Jordan and Singapore?
- 0.06 deaths per 100,000 people, with Jordan ahead.
- How many years of comparable data are there for Jordan and Singapore?
- 9 years are reported by both, from 2008 to 2018.
- How do Jordan and Singapore rank globally for prostate cancer death rate in men?
- Jordan ranks 89th and Singapore ranks 90th of 111 countries.
- Where does this data come from?
- WHO Mortality Database (2025) β with minor processing by Our World in Data, published as Prostate cancer death rate in men. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from prostate cancer in males in those aged all ages per 100,000 people.